Device Trial Radar · NCT05833945
Potential Use of a POCT for the Direct Transfer of Stroke Patients From the Ambulance to the Thrombectomy Center
Last checked: Nov 19, 2026Latest source record: Nov 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
355
Actual
Start
Apr 15, 2023
Primary completion
Jan 31, 2024
Study completion Apr 24, 2024
Sponsor
- Lead sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en SevillaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Hospital Universitario Virgen Macarena; Hospitales Universitarios Virgen del Rocío; Hospital Universitario Torrecárdenas; Hospital Universitario Poniente; Hospital Clínico Universitario Lozano Blesa; Hospital Miguel Servet; Hospital Universitario Royo Villanova; Hospital General San Jorge; Hospital San Pedro de Logroño; Hospital Clínico Universitario de Valladolid; Hospital Universitario La Fe; Complejo Hospitalario Universitario de Albacete; Hospital de Medina del Campo; Hospital General Río Carrión; Hospital General de Segovia; Hospital del Rio Hortega
- First posted
- Apr 27, 2023
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Stroke is the leading cause of long-term disability and the second most common cause of death worldwide. Currently, the protocols require the imaging techniques at the hospitals to differ ischemic strokes with large vessel occlusion (LVO) from others. In this study, a duplex POC will be used in combination with an APP to identify LVO ischemic strokes in a 800 patients'cohort with pre-hospital and in-hospital blood samples.
Conditions
- Stroke, Acute Ischemic
Interventions
Large Vessel Occlusion Biomarkers TestDevice
Duplex Point of Care test to measure the concentration of biomarkers associated to Large Vessel Occlusion in blood samples used in combination with an APP.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of the diagnosis accuracy of the algorithm LVOCheck (Specificity and sensibility)Time frame: 6 months
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Complejo Hospitalario Universitario Albacete
Albacete, Spain
Hospital Universitario Poniente
Almería, Spain
Hospital Universitario Torrecárdenas
Almería, Spain
13 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.